ESQLABS GMBH
Desconocido
Dypha: Dypha: adding the dimension of time to cell culture
ESQLABS GMBH
participó en un
HORIZON EUROPE:
HORIZON-EIC-2023-TRANSITION-01
The current preclinical drug development pipeline is highly inefficient with 9 out of 10 drugs failing when first tested in humans. Of those...
2024-03-12 - 2027-03-31 | Financiado
2024-03-12 - 2027-03-31 | Financiado
ONTOX: Ontology driven and artificial intelligence based repeated dose toxicity testing of chemicals for ne...
ESQLABS GMBH
participó en un
H2020:
H2020-SC1-BHC-2018-2020
The vision of the ONTOX consortium is to provide a functional and sustainable solution for advancing human risk assessment of chemicals with...
2021-01-29 - 2026-04-30 | Financiado
2021-01-29 - 2026-04-30 | Financiado
* No se disponen de datos de la empresa actual.